125 related articles for article (PubMed ID: 36435337)
1. Increased relative biological effectiveness and periventricular radiosensitivity in proton therapy of glioma patients.
Eulitz J; G C Troost E; Klünder L; Raschke F; Hahn C; Schulz E; Seidlitz A; Thiem J; Karpowitz C; Hahlbohm P; Grey A; Engellandt K; Löck S; Krause M; Lühr A
Radiother Oncol; 2023 Jan; 178():109422. PubMed ID: 36435337
[TBL] [Abstract][Full Text] [Related]
2. Late Contrast Enhancing Brain Lesions in Proton-Treated Patients With Low-Grade Glioma: Clinical Evidence for Increased Periventricular Sensitivity and Variable RBE.
Bahn E; Bauer J; Harrabi S; Herfarth K; Debus J; Alber M
Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):571-578. PubMed ID: 32234554
[TBL] [Abstract][Full Text] [Related]
3. A Monte Carlo based radiation response modelling framework to assess variability of clinical RBE in proton therapy.
Eulitz J; Lutz B; Wohlfahrt P; Dutz A; Enghardt W; Karpowitz C; Krause M; Troost EGC; Lühr A
Phys Med Biol; 2019 Nov; 64(22):225020. PubMed ID: 31374558
[TBL] [Abstract][Full Text] [Related]
4. How can scanned proton beam treatment planning for low-grade glioma cope with increased distal RBE and locally increased radiosensitivity for late MR-detected brain lesions?
Bauer J; Bahn E; Harrabi S; Herfarth K; Debus J; Alber M
Med Phys; 2021 Apr; 48(4):1497-1507. PubMed ID: 33506555
[TBL] [Abstract][Full Text] [Related]
5. Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma - How safe are protons?
Harrabi SB; von Nettelbladt B; Gudden C; Adeberg S; Seidensaal K; Bauer J; Bahn E; Mairani A; Alber M; Haberer T; Debus J; Herfarth K
Radiother Oncol; 2022 Feb; 167():211-218. PubMed ID: 34973277
[TBL] [Abstract][Full Text] [Related]
6. An empirical model of proton RBE based on the linear correlation between x-ray and proton radiosensitivity.
Flint DB; Ruff CE; Bright SJ; Yepes P; Wang Q; Manandhar M; Ben Kacem M; Turner BX; Martinus DKJ; Shaitelman SF; Sawakuchi GO
Med Phys; 2022 Sep; 49(9):6221-6236. PubMed ID: 35831779
[TBL] [Abstract][Full Text] [Related]
7. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
[TBL] [Abstract][Full Text] [Related]
8. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment.
Chaudhary P; Marshall TI; Perozziello FM; Manti L; Currell FJ; Hanton F; McMahon SJ; Kavanagh JN; Cirrone GA; Romano F; Prise KM; Schettino G
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):27-35. PubMed ID: 24986743
[TBL] [Abstract][Full Text] [Related]
9. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
10. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
[TBL] [Abstract][Full Text] [Related]
11. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
Giantsoudi D; Adams J; MacDonald SM; Paganetti H
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
[TBL] [Abstract][Full Text] [Related]
12. LET-weighted doses effectively reduce biological variability in proton radiotherapy planning.
McMahon SJ; Paganetti H; Prise KM
Phys Med Biol; 2018 Nov; 63(22):225009. PubMed ID: 30412471
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of clinical studies on variable proton Relative Biological Effectiveness (RBE).
Underwood TSA; McNamara AL; Appelt A; Haviland JS; Sørensen BS; Troost EGC
Radiother Oncol; 2022 Oct; 175():79-92. PubMed ID: 35988776
[TBL] [Abstract][Full Text] [Related]
14. Impact of potentially variable RBE in liver proton therapy.
Chen Y; Grassberger C; Li J; Hong TS; Paganetti H
Phys Med Biol; 2018 Sep; 63(19):195001. PubMed ID: 30183674
[TBL] [Abstract][Full Text] [Related]
15. Exploration and application of phenomenological RBE models for proton therapy.
Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
[TBL] [Abstract][Full Text] [Related]
16. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
[TBL] [Abstract][Full Text] [Related]
17. Range uncertainty in proton therapy due to variable biological effectiveness.
Carabe A; Moteabbed M; Depauw N; Schuemann J; Paganetti H
Phys Med Biol; 2012 Mar; 57(5):1159-72. PubMed ID: 22330133
[TBL] [Abstract][Full Text] [Related]
18. Clinical use and future requirements of relative biological effectiveness: Survey among all European proton therapy centres.
Heuchel L; Hahn C; Pawelke J; Sørensen BS; Dosanjh M; Lühr A
Radiother Oncol; 2022 Jul; 172():134-139. PubMed ID: 35605747
[TBL] [Abstract][Full Text] [Related]
19. Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury.
Giantsoudi D; Sethi RV; Yeap BY; Eaton BR; Ebb DH; Caruso PA; Rapalino O; Chen YE; Adams JA; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):287-296. PubMed ID: 26691786
[TBL] [Abstract][Full Text] [Related]
20. Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.
Underwood TS; Voog JC; Moteabbed M; Tang S; Soffen E; Cahlon O; Lu HM; Zietman AL; Efstathiou JA; Paganetti H
Acta Oncol; 2017 Apr; 56(4):575-581. PubMed ID: 28075206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
